Data updated: Mar 29, 2026

EMCURE PHARMS LTD

Oncology

Generics

EMCURE PHARMS LTD is a generic drug manufacturer focused on Oncology.

2012

Since

7

Drugs

-

Trials

54

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Recent Activity

GEMCITABINE HYDROCHLORIDE 2025-09-16

IRINOTECAN HYDROCHLORIDE 2025-08-20

IRINOTECAN HYDROCHLORIDE 2025-08-20

IRINOTECAN HYDROCHLORIDE 2025-08-20

IRINOTECAN HYDROCHLORIDE 2025-08-20

IRINOTECAN HYDROCHLORIDE 2025-08-20

ATAZANAVIR SULFATE 2025-08-12

ATAZANAVIR SULFATE 2025-08-12

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 100%

1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma

Novartis big-pharma

Merck big-pharma

Baxter specialty

AbbVie big-pharma